| 1 | To the Editor — Hemodynamic consequences of left atrial appendage occlusion | 0.8 | 0 | Citations (PDF) |
| 2 | Sodium-glucose cotransporter2 inhibitor-associated ketoacidosis in nondiabetic patients | 2.6 | 0 | Citations (PDF) |
| 3 | Atrio-oesophageal fistula after radiofrequency ablation of atrial fibrillation misinterpreted as COVID-19 infection | 0.9 | 0 | Citations (PDF) |
| 4 | Simultaneous occurrence of transient global amnesia and Takotsubo syndrome triggered by caring for a terminally ill relative | 0.6 | 0 | Citations (PDF) |
| 5 | Haemodynamic changes after interventional closure of the left atrial appendage may facilitate peri-device leaks | 2.2 | 0 | Citations (PDF) |
| 6 | Whether tamoxifen is beneficial for cardiac dysfunction in Duchenne muscular dystrophy requires appropriately designed studies | 2.3 | 0 | Citations (PDF) |
| 7 | Necrotizing pancreatitis, microangiopathic hemolytic anemia and thrombocytopenia following the second dose of Pfizer/BioNTech COVID-19 mRNA vaccine | 1.5 | 6 | Citations (PDF) |
| 8 | Stroke prevention in an octogenarian with atrial fibrillation, cerebral amyloid angiopathy and intracerebral hemorrhage | 0.6 | 1 | Citations (PDF) |
| 9 | Cannabidiol's impact on drug-metabolization | 2.6 | 5 | Citations (PDF) |
| 10 | Adverse events and drug–drug interactions of sodium glucose co-transporter 2 inhibitors in patients treated for heart failure | 1.8 | 0 | Citations (PDF) |
| 11 | Muscle bundles in hypertrophic cardiomyopathy: wallflowers seem to gain in importance | 1.4 | 1 | Citations (PDF) |
| 12 | Left ventricular trabeculations and cardiac magnetic resonance imaging | 1.8 | 0 | Citations (PDF) |
| 13 | Refinement of data is needed concerning the long-term prognosis of patients with takotsubo syndrome | 1.5 | 1 | Citations (PDF) |
| 14 | Successful pregnancy in left ventricular hypertrabeculation/noncompaction with implanted cardioverter/defibrillator and a variant in the TPM1 Gen (c.425A > T) in mother and child | 0.7 | 2 | Citations (PDF) |
| 15 | Aortic root replacement for aortic root aneurysm with severe aortic regurgitation and incidentally detected left ventricular hyper-trabeculation/noncompaction | 0.5 | 0 | Citations (PDF) |
| 16 | Stroke and embolism in patients with left ventricular hypertrabeculation/noncompaction | 1.7 | 5 | Citations (PDF) |
| 17 | Secondary stroke prevention in noncompaction by trabeculectomy? | 2.5 | 1 | Citations (PDF) |
| 18 | Update on drug interactions with non-vitamin-K-antagonist oral anticoagulants for stroke prevention in elderly patients | 2.9 | 5 | Citations (PDF) |
| 19 | Pulmonary Embolism and Acute Psychosis, a Case Report of an Outpatient with a Mild Course of COVID-19 | 0.5 | 5 | Citations (PDF) |
| 20 | Correlation between pathoanatomic findings, imaging modalities, and genetic findings in patients with left ventricular hypertrabeculation/noncompaction | 1.8 | 6 | Citations (PDF) |
| 21 | Reversal of systolic dysfunction in noncompaction and Wolff-Parkinson-White syndrome after accessory pathway ablation | 0.7 | 0 | Citations (PDF) |
| 22 | Subcutaneous implanted cardioverter‐defibrillator in ventricular noncompaction, coronary artery disease and stroke | 1.1 | 1 | Citations (PDF) |
| 23 | Reduced standards of scientific reporting in the COVID-19 pandemic? | 1.2 | 0 | Citations (PDF) |
| 24 | Myotonic dystrophy patients: More data about cardiac and neurologic findings would be useful | 3.4 | 1 | Citations (PDF) |
| 25 | Heart failure and late leaks should be considered as late complications of left atrial appendage occlusion | 1.9 | 1 | Citations (PDF) |
| 26 | Left Ventricular Noncompaction Syndrome: Genetic Insights and Therapeutic Perspectives | 3.1 | 18 | Citations (PDF) |
| 27 | NT‐pro‐BNP in patients with left ventricular hypertrabeculation/non‐compaction | 3.4 | 7 | Citations (PDF) |
| 28 | Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis | 3.4 | 3 | Citations (PDF) |
| 29 | Multisystem Myotilinopathy, including Myopathy and Left Ventricular Noncompaction, due to the MYOT Variant c.179C>T | 0.3 | 2 | Citations (PDF) |
| 30 | Unravel the genetic background of noncompaction before relating it with myocardial hypoperfusion | 3.4 | 2 | Citations (PDF) |
| 31 | Usefulness of Neuromuscular Co-morbidity, Left Bundle Branch Block, and Atrial Fibrillation to Predict the Long-Term Prognosis of Left Ventricular Hypertrabeculation/Noncompaction | 1.9 | 6 | Citations (PDF) |
| 32 | The attitude towards disease management programs in Austrian heart failure patients: a pilot study comparing rural and urban patients | 1.0 | 1 | Citations (PDF) |
| 33 | Noncompaction and Takotsubo Syndrome in a Neuromuscular Disorder | 0.3 | 1 | Citations (PDF) |
| 34 | Cardiac Diseases Relevant to Stroke 2019, , 154-168 | | 0 | Citations (PDF) |
| 35 | Fatal Recurrent Staphylococcus aureus Infection in a Patient With an Aortic Endostent Under Alirocumab | 1.6 | 1 | Citations (PDF) |
| 36 | Simultaneous transient global amnesia and Takotsubo syndrome after death of a relative: a case report | 0.9 | 9 | Citations (PDF) |
| 37 | Seizure-triggered Takotsubo syndrome – A need for cooperation between neurologists and cardiologists | 1.4 | 1 | Citations (PDF) |
| 38 | A 79‐year‐old woman with atrial fibrillation and new onset of heart failure | 3.4 | 9 | Citations (PDF) |
| 39 | Side effects of and contraindications for whole-body electro-myo-stimulation: a viewpoint | 2.4 | 21 | Citations (PDF) |
| 40 | Understanding left ventricular hypertrabeculation/noncompaction: pathomorphologic findings and prognostic impact of neuromuscular comorbidities | 1.8 | 19 | Citations (PDF) |
| 41 | Immediate versus delayed detection of Takotsubo syndrome after epileptic seizures | 1.4 | 13 | Citations (PDF) |
| 42 | Prognostic role of Pro-BNP levels in left ventricular hypertrabeculation/non-compaction and neuromuscular disorders: results of a pilot study | 1.0 | 2 | Citations (PDF) |
| 43 | Delayed onset of Takotsubo syndrome after epileptic seizure | 1.2 | 0 | Citations (PDF) |
| 44 | Neuromuscular Disorders and Noncompaction Cardiomyopathy 2019, , 41-60 | | 0 | Citations (PDF) |
| 45 | Management of noncompaction requires optimisation | 2.3 | 1 | Citations (PDF) |
| 46 | Reasons for missing noncompaction in myopathies and vice versa | 1.4 | 0 | Citations (PDF) |
| 47 | Tako-tsubo cardiomyopathy with transient global amnesia and cerebellar embolic stroke triggered by existential fear | 1.2 | 11 | Citations (PDF) |
| 48 | Suggestions for clinical studies about percutaneous left atrial appendage occlusion | 1.9 | 0 | Citations (PDF) |
| 49 | Myopathy, athletism, pregnancy, race, and chromosomal defects need to be considered in noncompaction | 1.0 | 0 | Citations (PDF) |
| 50 | Myopathy and Noncompaction Detected After Malignant Hyperthermia During Cardiac Surgery | 1.4 | 0 | Citations (PDF) |
| 51 | Takotsubo syndrome in a stroke patient with carotid artery stenosis | 1.2 | 0 | Citations (PDF) |
| 52 | Concomitant cardiac and cerebral takotsubo syndrome requires specific management | 2.1 | 0 | Citations (PDF) |
| 53 | Side effects of whole-body electro-myo-stimulation | 1.3 | 24 | Citations (PDF) |
| 54 | Acute myopathy as a side effect of electrostimulation | 1.3 | 1 | Citations (PDF) |
| 55 | Fragmented QRS Should be Correlated Not Only With Electrocardiogram but Also With Echocardiographic and Neuromuscular Parameters | 1.9 | 0 | Citations (PDF) |
| 56 | Hemopericardium under dabigatran for stroke prevention in atrial fibrillation | 1.0 | 10 | Citations (PDF) |
| 57 | Sudden unexpected death in epilepsy: A beneficial animal model | 1.9 | 0 | Citations (PDF) |
| 58 | Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors | 12.5 | 148 | Citations (PDF) |
| 59 | Recurrent venous thrombosis under rivaroxaban and carbamazepine for symptomatic epilepsy | 1.2 | 32 | Citations (PDF) |
| 60 | Varicella zoster virus meningitis under ustekinumab because of plaque psoriasis | 1.4 | 16 | Citations (PDF) |
| 61 | The Enigma of Left Ventricular Hypertrabeculation | 2.6 | 1 | Citations (PDF) |
| 62 | Drug interactions with new oral anticoagulants in elderly patients | 2.9 | 31 | Citations (PDF) |
| 63 | Atrial fibrillation and stroke as initial manifestations of painless type A aortic dissection | 1.2 | 3 | Citations (PDF) |
| 64 | Consider Cardiac, Neuromuscular, and Hereditary Aspects of Left Ventricular Hypertrabeculation or Noncompaction | 1.9 | 0 | Citations (PDF) |
| 65 | Concerns about the ESC heart failure guidelines | 2.2 | 1 | Citations (PDF) |
| 66 | Acute coronary syndrome in immigrants and non-immigrants | 1.5 | 0 | Citations (PDF) |
| 67 | Pulmonary embolism four days after interruption of therapy with rivaroxaban | 1.7 | 7 | Citations (PDF) |
| 68 | Biomarkers of Cardiac Disease in Duchenne Muscular Dystrophy are Insufficient in the Absence of Clinical Cardiologic and Neurologic Assessment | 1.3 | 0 | Citations (PDF) |
| 69 | Revision of Echocardiographic Indications and Findings in Neurologically Ill Patients | 0.2 | 1 | Citations (PDF) |
| 70 | Pipe Dreams About Apixaban for Stroke Prevention in Renal Impairment | 2.1 | 5 | Citations (PDF) |
| 71 | Does the Pathogenesis of Atrial Fibrillation Vary Between Hereditary and Non‐Hereditary Cardiac Disease? | 2.2 | 0 | Citations (PDF) |
| 72 | Comment on “Ventricular non‐compaction cardiomyopathy: prenatal diagnosis and pathology” | 2.6 | 1 | Citations (PDF) |
| 73 | Age-dependency of prescribing patterns of oral anticoagulant drugs in Austria during 2011–2014 | 1.9 | 12 | Citations (PDF) |
| 74 | Familial noncompaction on cardiac computed tomography | 2.2 | 1 | Citations (PDF) |
| 75 | Use of Direct-Acting Oral Anticoagulants in Nonagenarians: A Call for More Data | 3.5 | 14 | Citations (PDF) |
| 76 | Postnatal Outcome of Fetal Left Ventricular Hypertrabeculation/Noncompaction | 1.3 | 9 | Citations (PDF) |
| 77 | Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure? | 2.2 | 0 | Citations (PDF) |
| 78 | Autosomal dominant Carvajal plus syndrome due to the novel desmoplakin mutation c.1678A > T (p.Ile560Phe) | 1.3 | 8 | Citations (PDF) |
| 79 | Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs | 1.9 | 59 | Citations (PDF) |
| 80 | Bipolar disorder, ischemic stroke, mitral valve vegetation and recurrent venous thrombosis due to antiphospholipid syndrome despite rivaroxaban | 2.2 | 10 | Citations (PDF) |
| 81 | Unmet needs in the cardiologic and neurologic work-up of left ventricular hypertrabeculation/noncompaction | 1.8 | 6 | Citations (PDF) |
| 82 | Takotsubo-like syndrome triggered by fludrocortisone overdose for Addison’s disease: a case report | 0.9 | 12 | Citations (PDF) |
| 83 | Genetic, Myopathic, and Diagnostic Implications of Left Ventricular Noncompaction | 4.5 | 0 | Citations (PDF) |
| 84 | Independent data about the safety and efficacy of rivaroxaban for prevention of stroke/embolism are needed | 1.9 | 4 | Citations (PDF) |
| 85 | Fatal consequences of climbing a ladder under apixaban and drunken | 1.2 | 3 | Citations (PDF) |
| 86 | Carvajal syndrome with oligodontia, hypoacusis, recurrent infections, and noncompaction | 2.2 | 5 | Citations (PDF) |
| 87 | Sudden cardiac death in neuromuscular disorders | 2.2 | 36 | Citations (PDF) |
| 88 | Cardiologic and neurologic implications in Fabry disease with noncompaction | 0.9 | 0 | Citations (PDF) |
| 89 | Prevent Sudden Death in Carvajal Syndrome With Left Ventricular Hypertrabeculation/Noncompaction | 0.3 | 0 | Citations (PDF) |
| 90 | Consider the genetic and myopathic background, familial occurrence, and alternative definitions of left ventricular hypertrabeculation/noncompaction | 1.0 | 0 | Citations (PDF) |
| 91 | Explanations for discordance of noncompaction in monozygotic twins | 1.7 | 2 | Citations (PDF) |
| 92 | Non-compaction associated with an ACTC1 mutation | 1.6 | 1 | Citations (PDF) |
| 93 | Consider the neuro‐cardiac continuum of Coffin‐Lowry syndrome! | 1.7 | 1 | Citations (PDF) |
| 94 | Wearable Cardioverter-Defibrillator in a Patient with Left Ventricular Noncompaction/Hypertrabeculation, Coronary Artery Disease, and Polyneuropathy 2015, 20, 79-81 | | 3 | Citations (PDF) |
| 95 | Neuromuscular comorbidity, heart failure, and atrial fibrillation as prognostic factors in left ventricular hypertrabeculation/noncompaction | 0.8 | 33 | Citations (PDF) |
| 96 | Interobserver Agreement of the Echocardiographic Diagnosis of LV Hypertrabeculation/Noncompaction | 6.7 | 42 | Citations (PDF) |
| 97 | Role of desmoplakin mutations in the pathogenesis of non-compaction | 1.9 | 2 | Citations (PDF) |
| 98 | Embolism from noncompaction to different vascular territories | 2.2 | 2 | Citations (PDF) |
| 99 | Problems in Addition to Stroke and Bleeding After Left Atrial Appendage Closure | 1.9 | 0 | Citations (PDF) |
| 100 | Leriche-syndrome despite regular sport and non-compaction suggest neuromuscular disease | 2.2 | 4 | Citations (PDF) |
| 101 | Rivaroxaban 10mg/d in severe renal failure does not prevent ischemic events in premorbid neurologic disease | 1.2 | 1 | Citations (PDF) |
| 102 | PLEC1 mutation associated with left ventricular hypertrabeculation/noncompaction | 0.7 | 1 | Citations (PDF) |
| 103 | Primary prophylactic anticoagulation is mandatory if noncompaction is associated with atrial fibrillation or heart failure | 2.2 | 10 | Citations (PDF) |
| 104 | Age-Dependency of Cardiac and Neuromuscular Findings in Adults With Left Ventricular Hypertrabeculation/Noncompaction | 1.9 | 16 | Citations (PDF) |
| 105 | Exclude pregnancy, vigorous exercise and myopathy before diagnosing noncompaction in healthy subjects | 2.2 | 2 | Citations (PDF) |
| 106 | Letter by Stöllberger and Finsterer Regarding Article, “Reversible De Novo Left Ventricular Trabeculations in Pregnant Women: Implications for the Diagnosis of Left Ventricular Noncompaction in Low-Risk Populations” | 19.4 | 0 | Citations (PDF) |
| 107 | Fetal Ventricular Hypertrabeculation/Noncompaction: Clinical Presentation, Genetics, Associated Cardiac and Extracardiac Abnormalities and Outcome | 1.3 | 26 | Citations (PDF) |
| 108 | Fatal intracerebral bleeding under rivaroxaban | 2.2 | 18 | Citations (PDF) |
| 109 | Disabling myopathy with chorea and noncompaction | 2.2 | 1 | Citations (PDF) |
| 110 | Severe rhabdomyolysis after MIHA-bodytec® electrostimulation with previous mild hyper-CK-emia and noncompaction | 2.2 | 23 | Citations (PDF) |
| 111 | Familial Himalayan P Wave and Left Ventricular Hypertrabeculation/Noncompaction | 1.1 | 0 | Citations (PDF) |
| 112 | Disappearance of left ventricular hypertrabeculation/noncompaction in vacuolar non-neuromuscular cardiomyopathy | 2.2 | 5 | Citations (PDF) |
| 113 | A Probable Life-Saving Switch from Apixaban to Phenprocoumon | 0.4 | 2 | Citations (PDF) |
| 114 | Noncompaction in Healthy Subjects, Dilated and Hypertrophic Cardiomyopathy, and Neuromuscular Disorders Is the Same Entity | 0.3 | 2 | Citations (PDF) |
| 115 | Are RYR2 exon-3 deletions truly causative for non-compaction? | 1.9 | 2 | Citations (PDF) |
| 116 | Is Surgical Removal of the Noncompacted Layer the Clue to Treat Left Ventricular Hypertrabeculation/Noncompaction? | 0.9 | 1 | Citations (PDF) |
| 117 | Presentation, therapy and outcome of patients with ischemic stroke under new oral anticoagulants | 1.2 | 8 | Citations (PDF) |
| 118 | There is a need for independent studies about new oral anticoagulants in atrial fibrillation patients | 2.2 | 4 | Citations (PDF) |
| 119 | Diagnostic Problem of LV Hypertrabeculation/Noncompaction? | 6.7 | 1 | Citations (PDF) |
| 120 | Novel MYH7 mutation associated with mild myopathy but life-threatening ventricular arrhythmias and noncompaction | 2.2 | 15 | Citations (PDF) |
| 121 | Enterococcus faecalis bacteremia and mitral valve endocarditis under dabigatran for stroke prevention | 2.2 | 3 | Citations (PDF) |
| 122 | Prolonged anticoagulant activity of rivaroxaban in a polymorbid elderly female with non-convulsive epileptic state | 2.3 | 17 | Citations (PDF) |
| 123 | Repeated Radiofrequency Ablation of Atrial Tachycardia in Restrictive Cardiomyopathy Secondary to Myofibrillar Myopathy | 2.2 | 2 | Citations (PDF) |
| 124 | Noncompaction in alleged motor neuron disease suggests myopathy | 2.2 | 5 | Citations (PDF) |
| 125 | Ischemic stroke in left ventricular noncompaction and celiac disease | 2.2 | 4 | Citations (PDF) |
| 126 | To the Editor—Left atrium, vagal nerve, and esophagus: A neighborhood with close relations | 0.8 | 1 | Citations (PDF) |
| 127 | Left ventricular hypertrabeculation/noncompaction and pregnancy | 2.2 | 8 | Citations (PDF) |
| 128 | Cardiac diseases relevant to stroke 2014, , 140-154 | | 0 | Citations (PDF) |
| 129 | Evolution of Electrocardiographic Abnormalities in Association with Neuromuscular Disorders and Survival in Left Ventricular Hypertrabeculation/Noncompaction | 1.1 | 9 | Citations (PDF) |
| 130 | Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis? | 1.9 | 0 | Citations (PDF) |
| 131 | Cerebral hemorrhage under rivaroxaban | 2.2 | 15 | Citations (PDF) |
| 132 | Implantable loop-recorders in myopathic and non-myopathic patients with left ventricular hypertrabeculation/noncompaction | 2.2 | 5 | Citations (PDF) |
| 133 | Mitochondrial myopathy with disappearance of noncompaction within a thickening myocardium | 2.2 | 8 | Citations (PDF) |
| 134 | Cardiomyopathy in neurological disorders | 1.4 | 36 | Citations (PDF) |
| 135 | Unclassified cardiomyopathies in neuromuscular disorders | 1.3 | 13 | Citations (PDF) |
| 136 | Concerns About the Use of New Oral Anticoagulants for Stroke Prevention in Elderly Patients with Atrial Fibrillation | 3.5 | 30 | Citations (PDF) |
| 137 | Noncompaction predisposing for recurrent Takotsubo syndrome in myotonic dystrophy 1 | 2.2 | 13 | Citations (PDF) |
| 138 | Renal function, P-gp-affecting drugs and new anticoagulants for stroke prevention | 2.2 | 5 | Citations (PDF) |
| 139 | Aborted sudden unexplained death in epilepsy in a neuromuscular disorder leading to Takotsubo syndrome | 2.2 | 18 | Citations (PDF) |
| 140 | Left ventricular hypertrabeculation/noncompaction coincidentally found in sporadic inclusion body myositis | 2.2 | 5 | Citations (PDF) |
| 141 | Familal left ventricular hypertrabeculation (noncompaction) is myopathic | 2.2 | 34 | Citations (PDF) |
| 142 | New oral anticoagulants for stroke prevention in left ventricular hypertrabeculation/noncompaction? | 2.2 | 6 | Citations (PDF) |
| 143 | Prognosis of Duchenne/Becker muscular dystrophy with noncompaction is worse than without noncompaction | 2.2 | 5 | Citations (PDF) |
| 144 | Refinement of echocardiographic criteria for left ventricular noncompaction | 2.2 | 104 | Citations (PDF) |
| 145 | Stroke and urosepsis after discontinuation of rivaroxaban | 2.2 | 6 | Citations (PDF) |
| 146 | Pathomorphologic findings in left ventricular hypertrabeculation/noncompaction of adults in relation to neuromuscular disorders | 2.2 | 28 | Citations (PDF) |
| 147 | CHADS2- and CHA2DS2VASc Scores and Embolic Risk in Left Ventricular Hypertrabeculation/Noncompaction | 1.7 | 36 | Citations (PDF) |
| 148 | Compacta-thickness — A valuable or unhelpful criterion in the diagnosis of left ventricular noncompaction/hypertrabeculation? | 2.2 | 2 | Citations (PDF) |
| 149 | Quantitative Electrocardiographic Measures, Neuromuscular Disorders, and Survival in Left Ventricular Hypertrabeculation/Noncompaction | 1.1 | 12 | Citations (PDF) |
| 150 | Consider Danon disease in dilated cardiomyopathy with noncompaction | 2.6 | 3 | Citations (PDF) |
| 151 | Contra: “New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation” | 4.4 | 9 | Citations (PDF) |
| 152 | Thrombolysis of Ischemic Stroke From Noncompaction in Metabolic Myopathy | 1.1 | 4 | Citations (PDF) |
| 153 | Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation | 4.4 | 7 | Citations (PDF) |
| 154 | Is rivaroxaban safer and more effective than warfarin in patients with atrial fibrillation and stroke or TIA? | 19.1 | 0 | Citations (PDF) |
| 155 | Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention | 4.4 | 9 | Citations (PDF) |
| 156 | Left ventricular hypertrabeculation/non-compaction in a Duchenne/Becker muscular dystrophy carrier with epilepsy | 2.2 | 5 | Citations (PDF) |
| 157 | Progression of neurological and cardiovascular disease in left ventricular hypertrabeculation/noncompaction | 2.2 | 1 | Citations (PDF) |
| 158 | Neurological comorbidity affects prognosis in left ventricular hypertrabeculation/noncompaction | 2.3 | 19 | Citations (PDF) |
| 159 | Do pets reduce the likelihood of sudden unexplained death in epilepsy? | 2.3 | 14 | Citations (PDF) |
| 160 | Neuromuscular Aspects of Channelopathies With Left-Ventricular Hypertrabeculation/Noncompaction | 1.3 | 0 | Citations (PDF) |
| 161 | Cryptogenic embolic stroke in a girl with a trisomy 21 mosaic | 0.9 | 1 | Citations (PDF) |
| 162 | Myasthenia, Spondylitis and Enterococcus faecalis Endocarditis | 3.6 | 2 | Citations (PDF) |
| 163 | Authors' Reply | 1.9 | 0 | Citations (PDF) |
| 164 | Noncompaction in Neuromuscular Disorders Is Not at Variance From Noncompaction in Chromosomal Disorders, Congenital, or Non-Hereditary Disease | 1.9 | 0 | Citations (PDF) |
| 165 | Disappearance of Left Ventricular Hypertrabeculation/Noncompaction and Sudden Death in a Patient With Turner Mosaic Syndrome | 1.9 | 8 | Citations (PDF) |
| 166 | Concerns about storage and application of dabigatran and rivaroxaban | 2.2 | 7 | Citations (PDF) |
| 167 | Restrictive cardiomyopathy as a cardiac manifestation of myofibrillar myopathy | 2.3 | 5 | Citations (PDF) |
| 168 | Left ventricular hypertrabeculation/noncompaction associated with coronary heart disease and myopathy | 2.2 | 7 | Citations (PDF) |
| 169 | Noncompaction in a HIV-positive with cortical blindness as initial manifestation of progressive multifocal leucencephalopathy | 2.2 | 3 | Citations (PDF) |
| 170 | Overreaction to noncompaction in a patient with ankylosing spondylitis, Parkinson disease, migraine and myopathy | 2.2 | 8 | Citations (PDF) |
| 171 | Fatal outcome of aortic-valve endocarditis in noncompaction/hypertrabeculation | 2.2 | 5 | Citations (PDF) |
| 172 | Left ventricular hypertrabeculation/noncompaction in hereditary inclusion body myopathy | 2.2 | 14 | Citations (PDF) |
| 173 | Neuromuscular and cardiac comorbidity determines survival in 140 patients with left ventricular hypertrabeculation/noncompaction | 2.2 | 41 | Citations (PDF) |
| 174 | Metabolic myopathy with noncompaction in an African | 2.2 | 2 | Citations (PDF) |
| 175 | Stroke from noncompaction overlooked by echocardiography | 2.2 | 8 | Citations (PDF) |
| 176 | Unrecognized noncompaction on the internet | 2.2 | 1 | Citations (PDF) |
| 177 | Cardiac devices and neuromuscular disorders in left ventricular noncompaction | 2.2 | 7 | Citations (PDF) |
| 178 | Thromboembolism and ventricular thrombus in non-neuromuscular noncompaction | 2.2 | 4 | Citations (PDF) |
| 179 | Implantable loop recorders in myotonic dystrophy 1 | 2.2 | 10 | Citations (PDF) |
| 180 | Fatal septicemia in a patient with cerebral lymphoma and an Amplatzer septal occluder: a case report | 0.9 | 3 | Citations (PDF) |
| 181 | Frequency of Stroke and Embolism in Left Ventricular Hypertrabeculation/Noncompaction | 1.9 | 120 | Citations (PDF) |
| 182 | Left Ventricular Noncompaction/Hypertrabeculation: Distinctive Entity or Abnormality, Frequently Associated With Neuromuscular Disorders? | 1.9 | 4 | Citations (PDF) |
| 183 | Non-compaction and polyneuropathy in a patient homozygous for the H63D HFE gene mutation | 1.4 | 0 | Citations (PDF) |
| 184 | Aortitis requiring aortic repair associated with glaucoma, thyroiditis, glaucoma, and neuropathy: case report | 1.4 | 1 | Citations (PDF) |
| 185 | Noncompaction is already known in DiGeorge anomaly from 22q11.2 deletion | 1.7 | 4 | Citations (PDF) |
| 186 | Letter by Stöllberger et al Regarding Article, “Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation” | 6.2 | 0 | Citations (PDF) |
| 187 | A diagnostic dilemma in non-compaction, resulting in near expulsion from the football world cup | 2.4 | 15 | Citations (PDF) |
| 188 | Clinical Implications of MRI To Assess Cardiac and Pulmonary Function in Patients With Duchenne Muscular DystrophyChest, 2010, 138, 756-757 | 0.5 | 1 | Citations (PDF) |
| 189 | Even Isolated Left Ventricular Hypertrabeculation May Indicate Multisystem Disease | 1.8 | 0 | Citations (PDF) |
| 190 | Assault-induced Takotsubo cardiomyopathy associated with persisting anterograde amnesia and myopathy | 2.0 | 21 | Citations (PDF) |
| 191 | Low-voltage electrocardiogram in a comatose patient after endoscopic retrograde cholangiopancreatography | 0.9 | 1 | Citations (PDF) |
| 192 | Stroke prevention by means of left atrial appendage strangulation? | 2.9 | 0 | Citations (PDF) |
| 193 | Consider Cardiac, Neuromuscular, and Chromosomal Comorbidities in Left Ventricular Hypertrabeculation/Noncompaction | 1.9 | 0 | Citations (PDF) |
| 194 | Chromosomal Abnormalities and Neuromuscular Disorders Predict Severity and Outcome of Noncompaction in Addition to Cardiac Comorbidities | 4.2 | 3 | Citations (PDF) |
| 195 | Can cardiac magnetic resonance imaging resolve cardiac and neurological enigmas of left ventricular hypertrabeculation/non-compaction? | 1.4 | 0 | Citations (PDF) |
| 196 | Acquired noncompaction associated with coronary heart disease and myopathy | 2.3 | 16 | Citations (PDF) |
| 197 | In- and outpatients with noncompaction: Differences in cardiac and neuromuscular co-morbidity | 2.2 | 2 | Citations (PDF) |
| 198 | Ventricular dysfunction and number of non compacted segments in non compaction: Non-independent predictors | 2.2 | 23 | Citations (PDF) |
| 199 | Consider potential pitfalls, myopathy and chromosomal abnormalities when diagnosing left ventricular hypertrabeculation/noncompaction | 2.2 | 3 | Citations (PDF) |
| 200 | Morphology does not always explain pathogenesis | 2.2 | 3 | Citations (PDF) |
| 201 | Consensus on unsolved issues of left ventricular hypertrabeculation/noncompaction is warranted | 2.2 | 1 | Citations (PDF) |
| 202 | Coronary angiography in noncompaction with and without neuromuscular disorders | 1.2 | 5 | Citations (PDF) |
| 203 | Neuromuscular Disorders in Left Ventricular Hypertrabeculation/Noncompaction | 2.3 | 31 | Citations (PDF) |
| 204 | Isolated left ventricular hypertrabeculation/noncompaction in a Turner mosaic with male phenotype | 1.6 | 13 | Citations (PDF) |
| 205 | Cardiac diseases relevant to stroke 2009, , 105-120 | | 0 | Citations (PDF) |
| 206 | Priapism as a manifestation of tetania | 1.2 | 0 | Citations (PDF) |
| 207 | Cardiac and neurological implications in beta-thalassemia with left ventricular hypertrabeculation/non-compaction | 2.4 | 0 | Citations (PDF) |
| 208 | Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy | 3.0 | 3 | Citations (PDF) |
| 209 | Hypertrophe Kardiomyopathie | 0.0 | 0 | Citations (PDF) |
| 210 | Risk of Stroke and Thrombus Formation From Delay Incontinence of a PLAATO‐Device in Friedreich Ataxia | 2.1 | 2 | Citations (PDF) |
| 211 | Myopathy, Left Ventricular Noncompaction, and Tetralogy of Fallot | 2.1 | 5 | Citations (PDF) |
| 212 | Atrial fibrillation in left ventricular noncompaction with and without neuromuscular disorders is associated with a poor prognosis | 2.2 | 24 | Citations (PDF) |
| 213 | Stroke from paroxysmal atrial flutter or left ventricular hypertrabeculation/noncompaction, visible only on transesophageal echocardiography | 2.2 | 1 | Citations (PDF) |
| 214 | Noncompaction and Takotsubo syndrome require cardiac, neurological, and genetic investigations | 2.2 | 1 | Citations (PDF) |
| 215 | Septal hypertrabeculation/noncompaction: Cardiac and neurologic implications | 2.2 | 13 | Citations (PDF) |
| 216 | Cardiac and neuromuscular implications of left bundle branch block in left ventricular hypertrabeculation/noncompaction | 1.9 | 5 | Citations (PDF) |
| 217 | To the Editor | 0.8 | 40 | Citations (PDF) |
| 218 | Neurological Consequences of Atrioesophageal Fistula After Radiofrequency Ablation in Atrial Fibrillation | 6.8 | 48 | Citations (PDF) |
| 219 | Myopathy, apical hypertrophic cardiomyopathy and left ventricular noncompaction within the same family | 1.6 | 6 | Citations (PDF) |
| 220 | Stroke and peripheral embolism from an Amplatzer septal occluder 5 years after implantation | 3.4 | 13 | Citations (PDF) |
| 221 | Diagnosing Left Ventricular Noncompaction by Echocardiography and Cardiac Magnetic Resonance Imaging and Its Dependency on Neuromuscular Disorders | 2.1 | 26 | Citations (PDF) |
| 222 | Electrocardiographic abnormalities in opiate addicts | 6.1 | 22 | Citations (PDF) |
| 223 | Diferencias de sexo en la ausencia de compactación ventricular izquierda con y sin trastornos neuromusculares | 1.1 | 30 | Citations (PDF) |
| 224 | Sex Differences in Left Ventricular Noncompaction in Patients With and Without Neuromuscular Disorders | 0.5 | 13 | Citations (PDF) |
| 225 | Definite, probable, or possible left ventricular hypertrabeculation/noncompaction | 2.2 | 28 | Citations (PDF) |
| 226 | Noncompaction and endocarditis in suspected mitochondrial disorder | 2.2 | 16 | Citations (PDF) |
| 227 | Noncompaction in a nonagenarian with recurrent neurological deficits | 2.2 | 2 | Citations (PDF) |
| 228 | Significance of CK-elevation in noncompaction with regard to cardiac and neuromuscular disease | 2.2 | 5 | Citations (PDF) |
| 229 | How to define noncompaction? | 2.2 | 1 | Citations (PDF) |
| 230 | Cerebrovascular events in left ventricular hypertrabeculation/noncompaction with and without myopathy | 2.2 | 26 | Citations (PDF) |
| 231 | Cardiac involvement in Becker muscular dystrophy | 1.9 | 61 | Citations (PDF) |
| 232 | Primary myopathies and the heart | 0.9 | 65 | Citations (PDF) |
| 233 | Prevalence of Barth syndrome in adult left ventricular hypertrabeculation / noncompaction | 0.9 | 4 | Citations (PDF) |
| 234 | Acquired left ventricular noncompaction as a cardiac manifestation of neuromuscular disorders | 0.9 | 64 | Citations (PDF) |
| 235 | Anticoagulant drugs in noncompaction: a mandatory therapy? | 1.2 | 29 | Citations (PDF) |
| 236 | Myopathic background of non-compaction in children | 2.2 | 0 | Citations (PDF) |
| 237 | Cardiac resynchronization therapy in left ventricular hypertrabeculation/non-compaction and myopathy | 1.9 | 25 | Citations (PDF) |
| 238 | Arguments Against Left Atrial Appendage Occlusion for Stroke Prevention | 6.2 | 7 | Citations (PDF) |
| 239 | Don't miss extra-cardiac manifestations of familial left ventricular hypertrabeculation/non-compact | 8.2 | 0 | Citations (PDF) |
| 240 | Myopathy associated with spherocytosis and left ventricular hypertrabeculation/noncompaction | 8.2 | 3 | Citations (PDF) |
| 241 | Genetic background of left ventricular hypertrabeculation/non-compaction with stroke | 1.9 | 0 | Citations (PDF) |
| 242 | Left ventricular noncompaction or papillary muscle? | 1.2 | 1 | Citations (PDF) |
| 243 | Apical hypertrophic cardiomyopathy in encephalomyopathy | 1.2 | 4 | Citations (PDF) |
| 244 | Differential diagnoses and extracardiac manifestations in left ventricular noncompaction | 1.2 | 0 | Citations (PDF) |
| 245 | Left ventricular hypertrabeculation (noncompaction) with prominent calcifications in a patient with mannose-binding lectin deficiency and unclassified myopathy | 1.4 | 6 | Citations (PDF) |
| 246 | Magnetic resonance imaging does not always confirm left ventricular noncompaction | 2.2 | 6 | Citations (PDF) |
| 247 | Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication | 2.2 | 10 | Citations (PDF) |
| 248 | Acquired noncompaction | 2.2 | 1 | Citations (PDF) |
| 249 | Acquired noncompaction associated with myopathy | 2.2 | 42 | Citations (PDF) |
| 250 | Prognosis of left ventricular hypertrabeculation/noncompaction is dependent on cardiac and neuromuscular comorbidity | 2.2 | 60 | Citations (PDF) |
| 251 | WATCHMAN for Stroke Prevention: An Out-of-Date Procedure | 2.6 | 0 | Citations (PDF) |
| 252 | Disappearance of Left Ventricular Hypertrabeculation/Noncompaction After Biventricular Pacing in a Patient With Polyneuropathy | 1.3 | 48 | Citations (PDF) |
| 253 | Genetic heterogeneity of noncompaction | 4.5 | 2 | Citations (PDF) |
| 254 | To the Editor: | 2.2 | 0 | Citations (PDF) |
| 255 | Noncompaction in Melnick Fraser Syndrome | 1.1 | 4 | Citations (PDF) |
| 256 | Serious Complications from Dislocation of a Watchman Left Atrial Appendage Occluder | 2.2 | 34 | Citations (PDF) |
| 257 | Superiority of Contrast Echocardiography Over Conventional Echocardiography in Diagnosing Left Ventricular Hypertrabeculation/Noncompaction | 1.9 | 2 | Citations (PDF) |
| 258 | Complete heart block associated with noncompaction, nail-patella syndrome, and mitochondrial myopathy | 0.9 | 19 | Citations (PDF) |
| 259 | Leave the left atrial appendage untouched for stroke prevention! | 2.9 | 0 | Citations (PDF) |
| 260 | Extracardiac Medical and Neuromuscular Implications in Restrictive Cardiomyopathy | 2.1 | 23 | Citations (PDF) |
| 261 | Noncompaction and Neuromuscular Disease with Positive Troponin-T in a Nonagenerian | 2.1 | 5 | Citations (PDF) |
| 262 | Cardiologic and neuromuscular co-morbidity influences mortality of patients with left ventricular hypertrabeculation/noncompaction | 1.6 | 3 | Citations (PDF) |
| 263 | Consider Neuromuscular Disorders in Association with Noncompaction | 0.5 | 0 | Citations (PDF) |
| 264 | Transient left ventricular dysfunction (tako-tsubo phenomenon): Findings and potential pathophysiological mechanisms | 1.9 | 29 | Citations (PDF) |
| 265 | Hypertrabeculation Is Not Distinct from Noncompaction in Neuromuscular and Nonneuromuscular Disorders | 4.2 | 1 | Citations (PDF) |
| 266 | Left Ventricular Noncompaction, Cardiac Magnetic Resonance Imaging, and Neuromuscular Disorders | 2.6 | 6 | Citations (PDF) |
| 267 | Does Percutaneous Closure of the Left Atrial Appendage Prevent Stroke in Atrial Fibrillation? | 2.6 | 2 | Citations (PDF) |
| 268 | Non-indicated Oral Anticoagulation in Left Ventricular Hypertrabeculation/Noncompaction May Jeopardize These Patients | 0.4 | 1 | Citations (PDF) |
| 269 | Cardiology and neurologic family screening in noncompaction | 2.9 | 0 | Citations (PDF) |
| 270 | Benefits of left atrial appendage occlusion for stroke prevention | 2.9 | 77 | Citations (PDF) |
| 271 | WATCHMAN: An effective protection against stroke? | 2.9 | 1 | Citations (PDF) |
| 272 | Non-compacted hearts require thorough cardiac and neurologic diagnostic work-up | 0.8 | 0 | Citations (PDF) |
| 273 | Left ventricular hypertrabeculation/noncompaction requires comprehensive cardiological and neurological examinations | 2.4 | 1 | Citations (PDF) |
| 274 | Acquired noncompaction in Duchenne muscular dystrophy | 2.2 | 70 | Citations (PDF) |
| 275 | Autonomic dysfunction in left ventricular hypertrabeculation/noncompaction | 2.2 | 2 | Citations (PDF) |
| 276 | Age-dependency of cardiac and neuromuscular findings in left ventricular noncompaction | 2.2 | 28 | Citations (PDF) |
| 277 | Neuromuscular implications in left ventricular hypertrabeculation/noncompaction | 2.2 | 90 | Citations (PDF) |
| 278 | Cardiologic and neurologic implications of left ventricular hypertrabeculation, also termed noncompaction | 0.9 | 1 | Citations (PDF) |
| 279 | Safety of Oral Anticoagulation in Elderly Atrial Fibrillation Patients to Prevent Strokes | 6.2 | 0 | Citations (PDF) |
| 280 | Right-Sided Hypertrophic Cardiomyopathy with Generalized Wasting | 2.2 | 4 | Citations (PDF) |
| 281 | Staphylococcus warneri endocarditis after implantation of a lumbar disc prosthesis in an immunocompetent patient | 2.9 | 31 | Citations (PDF) |
| 282 | Successful heart failure therapy in mitochondrial disorder with noncompaction cardiomyopathy | 1.3 | 5 | Citations (PDF) |
| 283 | Myocardial and skeletal muscle biopsy in left ventricular hypertrabeculation/noncompaction | 1.2 | 0 | Citations (PDF) |
| 284 | Cardiac MRI versus echocardiography in assessing noncompaction in children without neuromuscular disease | 2.0 | 7 | Citations (PDF) |
| 285 | Stroke prevention by means of epicardial occlusion of the left atrial appendage | 2.9 | 1 | Citations (PDF) |
| 286 | Cardiac and neuromuscular implications in left ventricular hypertrabeculation/non-compaction | 1.9 | 0 | Citations (PDF) |
| 287 | Title is missing! | 2.4 | 0 | Citations (PDF) |
| 288 | “Management of cardiac involvement in neuromuscular disorders” | 3.9 | 0 | Citations (PDF) |
| 289 | Postpartum Syncope and Noncompaction in Suspected Encephalomyopathy | 0.5 | 3 | Citations (PDF) |
| 290 | Echocardiographically suspected hypertrabeculation/noncompaction confirmed by magnetic resonance imaging in metabolic myopathy | 1.6 | 0 | Citations (PDF) |
| 291 | Antipsychotic drugs and QT prolongation | 1.7 | 137 | Citations (PDF) |
| 292 | Evident, but poorly defined: left ventricular hypertrabeculation/noncompaction and its diagnostic criteria | 2.2 | 1 | Citations (PDF) |
| 293 | A Puzzling Intrauterine Death: Non-Compaction of the Fetal Ventricular Myocardium Presenting With Reversed End-Diastolic Flow Velocity in the Umbilical Arteries | 0.7 | 0 | Citations (PDF) |
| 294 | Uncertainties in Left Ventricular Hypertrabeculation/Noncompaction | 1.8 | 0 | Citations (PDF) |
| 295 | Is left ventricular hypertrabeculation/noncompaction dependent on ventricular shape and function? | 1.9 | 0 | Citations (PDF) |
| 296 | Outcome of Left Ventricular Hypertrabeculation/Noncompaction in Children | 1.9 | 4 | Citations (PDF) |
| 297 | The heart in muscular dystrophies | 0.1 | 4 | Citations (PDF) |
| 298 | Cardiologic and neurologic findings in left ventricular hypertrabeculation/non‐compaction related to wall thickness, size and systolic function | 8.2 | 25 | Citations (PDF) |
| 299 | Causes of left ventricular hypertrabeculation/non-compaction in a neonate and her mother | 1.3 | 0 | Citations (PDF) |
| 300 | Comment on stroke with atrial fibrillation: data from the Austrian stroke registry: reply | 2.2 | 0 | Citations (PDF) |
| 301 | Left ventricular synchronization by biventricular pacing in Becker muscular dystrophy as assessed by tissue Doppler imaging | 2.3 | 18 | Citations (PDF) |
| 302 | Stroke in diabetic and non‐diabetic patients: Course and prognostic value of admission serum glucose | 3.9 | 51 | Citations (PDF) |
| 303 | Factors influencing mortality in atrial fibrillation. Post hoc analysis of an observational study in outpatients | 2.2 | 19 | Citations (PDF) |
| 304 | Unresolved issues in left ventricular hypertrabeculation/noncompaction | 2.2 | 1 | Citations (PDF) |
| 305 | Clinical relevance of plasma brain natriuretic peptide in patients with Duchenne and Becker muscular dystrophy | 0.7 | 3 | Citations (PDF) |
| 306 | Eosinophilic pericardial effusion in Churg–Strauss syndrome | 2.8 | 14 | Citations (PDF) |
| 307 | Answer to the Letter to the Editor | 2.8 | 1 | Citations (PDF) |
| 308 | Effects of percutaneous left atrial appendage transcatheter occlusion (PLAATO) on left atrial structure and function | 2.6 | 6 | Citations (PDF) |
| 309 | Worsening of Heart Failure in Becker Muscular Dystrophy After Nonsteroidal Anti-inflammatory Drugs | 0.5 | 9 | Citations (PDF) |
| 310 | Left ventricular hypertrabeculation/noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation | 1.6 | 23 | Citations (PDF) |
| 311 | Is Turner's syndrome associated with cardiomyopathy and myopathy? | 0.9 | 2 | Citations (PDF) |
| 312 | Thrombi in the left ventricular hypertrabeculation/noncompaction | 1.6 | 34 | Citations (PDF) |
| 313 | Comparison of Two Tests for Serum .ALPHA.-Galactosidase in Nonneuromuscular Left Ventricular Hypertrabeculation/Noncompaction | 1.0 | 1 | Citations (PDF) |
| 314 | Left Ventricular Noncompaction Suggests Myopathy | 19.4 | 10 | Citations (PDF) |
| 315 | Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study | 2.1 | 47 | Citations (PDF) |
| 316 | Left ventricular hypertrabeculation/noncompaction?don?t forget the myologist! | 0.1 | 0 | Citations (PDF) |
| 317 | Brain or heart?that is the question | 0.1 | 1 | Citations (PDF) |
| 318 | Heterogenous myopathic background of left ventricular hypertrabeculation/noncompaction 2004, 131A, 221-221 | | 2 | Citations (PDF) |
| 319 | Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP) | 1.9 | 189 | Citations (PDF) |
| 320 | Trabeculation and left ventricular hypertrabeculation/noncompaction | 4.2 | 15 | Citations (PDF) |
| 321 | Left ventricular noncompaction requires the neurologist | 4.2 | 4 | Citations (PDF) |
| 322 | Left ventricular hypertrabeculation/noncompaction | 4.2 | 376 | Citations (PDF) |
| 323 | Left ventricular hypertrabeculation/noncompaction with and without neuromuscular disorders | 2.2 | 30 | Citations (PDF) |
| 324 | Myoadenylate-deaminase gene mutation associated with left ventricular hypertrabeculation/non-compaction | 1.6 | 23 | Citations (PDF) |
| 325 | Lone noncompaction in Leber's hereditary optic neuropathy | 1.6 | 11 | Citations (PDF) |
| 326 | Left ventricular hypertrabeculation/noncompaction and neuromuscular disorders in idiopathic dilated cardiomyopathy | 1.6 | 4 | Citations (PDF) |
| 327 | Familial Left Ventricular Hypertrabeculation
in Myotonic Dystrophy Type 1 | 0.8 | 22 | Citations (PDF) |
| 328 | Left atrial appendage morphology: comparison of transesophageal images and postmortem casts | 0.1 | 27 | Citations (PDF) |
| 329 | Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up | 5.0 | 33 | Citations (PDF) |
| 330 | Atherosclerosis: infection-induced involvement of mitochondrial chaperonins | 35.3 | 8 | Citations (PDF) |
| 331 | Ischemic Stroke and Splenic Rupture in a Case of
Streptococcus bovis
Endocarditis | 4.1 | 9 | Citations (PDF) |
| 332 | Is Percutaneous Left Atrial Appendage Transcatheter Occlusion an Alternative to Oral Anticoagulation in Patients With Atrial Fibrillation? | 19.4 | 9 | Citations (PDF) |
| 333 | Elimination of the Left Atrial Appendage To Prevent Stroke or Embolism?Chest, 2003, 124, 2356-2362 | 0.5 | 99 | Citations (PDF) |
| 334 | Reflux Esophagitis in the Pathogenesis of Paroxysmal Atrial Fibrillation: Results of a Pilot Study | 0.5 | 37 | Citations (PDF) |
| 335 | Non-compaction on echocardiography and autopsy | 1.6 | 8 | Citations (PDF) |
| 336 | Role of Infectious and Immune Factors in Coronary and Cerebrovascular Arteriosclerosis | 3.5 | 18 | Citations (PDF) |
| 337 | Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders | 1.9 | 479 | Citations (PDF) |
| 338 | Title is missing! | 1.9 | 4 | Citations (PDF) |
| 339 | Intramyocardial hematoma mimicking abnormal left ventricular trabeculation | 4.2 | 22 | Citations (PDF) |
| 340 | Left Ventricular Hypertrabeculation in Myotonic Dystrophy Type 1 | 0.8 | 27 | Citations (PDF) |
| 341 | Toothache leading to emergency cardiac surgery | 5.2 | 2 | Citations (PDF) |
| 342 | Der Stellenwert der Dobutamin-Stressechokardiographie im Routinebetrieb einer Kardiologischen Abteilung | 1.1 | 2 | Citations (PDF) |
| 343 | Isolated left ventricular abnormal trabeculation in adults is associated with neuromuscular disorders | 2.1 | 15 | Citations (PDF) |
| 344 | Transesophageal Echocardiography To Assess Embolic Risk in Patients with Atrial Fibrillation | 10.5 | 136 | Citations (PDF) |
| 345 | Morphology of the left atrial appendage | 0.0 | 167 | Citations (PDF) |
| 346 | Noncompaction and the novel variant c.425A>T in TPM1 | 1.6 | 1 | Citations (PDF) |
| 347 | Isolated Non-Compaction Cardiomyopathy | 0.2 | 55 | Citations (PDF) |
